Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Number of holders
-
272
-
Total 13F shares, excl. options
-
178,006,422
-
Shares change
-
+12,068,525
-
Total reported value, excl. options
-
$3,241,831,055
-
Value change
-
+$139,183,084
-
Put/Call ratio
-
82%
-
Number of buys
-
154
-
Number of sells
-
-160
-
Price
-
$18.22
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q3 2019
377 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2019.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 272 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 178,006,422 shares
.
Largest 10 shareholders include Invesco Ltd. (34,643,386 shares), PRIMECAP MANAGEMENT CO/CA/ (19,123,222 shares), VANGUARD GROUP INC (17,828,305 shares), WELLINGTON MANAGEMENT GROUP LLP (16,500,943 shares), BlackRock Inc. (13,558,280 shares), FMR LLC (13,130,036 shares), STATE STREET CORP (7,419,493 shares), Bellevue Group AG (3,172,886 shares), Camber Capital Management LP (3,000,000 shares), and GEODE CAPITAL MANAGEMENT, LLC (2,814,872 shares).
This table shows the top 272 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.